Trident Lifeline has made an additional investment in its subsidiary -- TNS PHARMA by acquiring 10,20,000 equity shares. Consequently, the company’s total shareholding percentage in the subsidiary remains unchanged at 51%.
Trident Lifeline is engaged in the pharmaceutical business ethical marketing in domestic as well as international market.